Gene Activity List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 41 of 1714:
31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51
Gene Compound Assay Inh Ic50 Ki View
phosphodiesterase 4A, cAMP specific RO 20-1724 Phosphodiesterase PDE4 71% 11.316uM NoneNone View
phosphodiesterase 4C, cAMP-specific RO 20-1724 Phosphodiesterase PDE4 71% 11.316uM NoneNone View
phosphodiesterase 4D RO 20-1724 Phosphodiesterase PDE4 71% 11.316uM NoneNone View
phosphodiesterase 4B, cAMP specific RO 20-1724 Phosphodiesterase PDE4 71% 11.316uM NoneNone View
5-hydroxytryptamine receptor 6 DICYCLOMINE Serotonin 5-HT6 71% 3.065uM 1.423uM View
5-hydroxytryptamine (serotonin) receptor 1B CLOZAPINE Serotonin 5-HT1B 71% 2.109uM .959uM View
ATPase, Na+/K+ transporting, alpha 4 polypeptide CHLORMADINONE ACETATE ATPase, Na+/K+ 71% 4.5696uM NoneNone View
ATPase, Na+/K+ transporting, alpha 3 polypeptide CHLORMADINONE ACETATE ATPase, Na+/K+ 71% 4.5696uM NoneNone View
ATPase, Na+/K+ transporting, alpha 2 polypeptide CHLORMADINONE ACETATE ATPase, Na+/K+ 71% 4.5696uM NoneNone View
ATPase, Na+/K+ transporting, alpha 1 polypeptide CHLORMADINONE ACETATE ATPase, Na+/K+ 71% 4.5696uM NoneNone View
opioid receptor, sigma 1 PERHEXILINE Sigma1 71% 2.5992uM 1.0924uM View
cholinergic receptor, muscarinic 4 SULOCTIDIL Muscarinic M4 71% 4.561uM .6361uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 ZINC CHLORIDE Adrenergic, Norepinephrine Transporter 71% 7.0083uM 6.9504uM View
opioid receptor, sigma 1 PROPAFENONE Sigma1 71% 2.61uM 1.097uM View
Sigma-2 Receptor 1,3-DIPHENYLGUANIDINE Sigma2 71% 2.641uM 1.625uM View
5-hydroxytryptamine (serotonin) receptor 2C 4-NONYLPHENOL Serotonin 5-HT2C 71% 2.571uM 1.347uM View
adrenergic receptor, alpha 2a THIORIDAZINE Imidazoline I2, Central 71% 3.663uM 2.442uM View
adrenergic receptor, alpha 2c (Non-specific probe) THIORIDAZINE Imidazoline I2, Central 71% 3.663uM 2.442uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 HYDROXYPROGESTERONE Dopamine Transporter 71% 6.905uM 5.486uM View
Cytochrom P450-2D6 monooxygenase LEVOBUPIVACAINE CYP450-2D6 Inhibition 71% .1964uM NoneNone View
Cytochrom P450-2D6 monooxygenase PIPERILATE ETHOBROMIDE CYP450-2D6 Inhibition 71% .521uM NoneNone View
Cytochrom P450-2D6 monooxygenase THIMEROSAL CYP450-2D6 Inhibition 71% 3uM NoneNone View
Cytochrom P450-2D6 monooxygenase AMOXAPINE CYP450-2D6 Inhibition 71% 10uM NoneNone View
Cytochrom P450-2D6 monooxygenase CLOMIPRAMINE CYP450-2D6 Inhibition 71% 3.9465uM NoneNone View
Cytochrom P450-2C19 monooxygenase TIBOLONE CYP450-2C19 Inhibition 71% 3uM NoneNone View
Cytochrom P450-2C19 monooxygenase PAPAVERINE CYP450-2C19 Inhibition 71% .762uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B BERBERINE CHLORIDE Serotonin 5-HT2B 71% 3.437uM 2.187uM View
adrenergic receptor, alpha 2a METHYLERGONOVINE Imidazoline I2, Central 71% 2.934uM 1.956uM View
adrenergic receptor, alpha 2c (Non-specific probe) METHYLERGONOVINE Imidazoline I2, Central 71% 2.934uM 1.956uM View
dopamine receptor 2 MAPROTILINE Dopamine D2L 71% 3.463uM 1.154uM View
calcium channel, voltage-dependent, gamma subunit 8 MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, gamma subunit 7 MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, gamma subunit 6 MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, gamma subunit 5 MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, gamma subunit 4 MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, gamma subunit 3 MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, gamma subunit 2 MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
sodium channel, voltage-gated, type IV, beta PUROMYCIN Sodium Channel, Site 2 12% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, beta 4 subunit MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, beta 3 subunit MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, beta 2 subunit MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, alpha 1F subunit MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, alpha 1F subunit DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
adrenergic receptor, alpha 2b SULPIRIDE Adrenergic alpha2B 69% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit NELFINAVIR Calcium Channel Type L, Phenylalkylamine 69% 18.38uM 17.862uM View
calcium channel, voltage-dependent, beta 3 subunit NELFINAVIR Calcium Channel Type L, Phenylalkylamine 69% 18.38uM 17.862uM View
calcium channel, voltage-dependent, beta 2 subunit NELFINAVIR Calcium Channel Type L, Phenylalkylamine 69% 18.38uM 17.862uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit NELFINAVIR Calcium Channel Type L, Phenylalkylamine 69% 18.38uM 17.862uM View
calcium channel, voltage-dependent, alpha 1F subunit NELFINAVIR Calcium Channel Type L, Phenylalkylamine 69% 18.38uM 17.862uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit NELFINAVIR Calcium Channel Type L, Phenylalkylamine 69% 18.38uM 17.862uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit NELFINAVIR Calcium Channel Type L, Phenylalkylamine 69% 18.38uM 17.862uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit NELFINAVIR Calcium Channel Type L, Phenylalkylamine 69% 18.38uM 17.862uM View
calcium channel, voltage-dependent, beta 1 subunit NELFINAVIR Calcium Channel Type L, Phenylalkylamine 69% 18.38uM 17.862uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit NELFINAVIR Calcium Channel Type L, Phenylalkylamine 69% 18.38uM 17.862uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit NELFINAVIR Calcium Channel Type L, Phenylalkylamine 69% 18.38uM 17.862uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 NELFINAVIR Calcium Channel Type L, Phenylalkylamine 69% 18.38uM 17.862uM View
histamine receptor H 2 NIZATIDINE Histamine H2 69% NoneNone NoneNone View
adrenergic receptor, alpha 2b CYCLIZINE Adrenergic alpha2C 69% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) CYCLIZINE Adrenergic alpha2C 69% NoneNone NoneNone View
cholinergic receptor, muscarinic 1 TACRINE Muscarinic M1 69% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 1A PHENELZINE Serotonin 5-HT1A 69% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 ETHYNODIOL DIACETATE Adrenergic, Norepinephrine Transporter 69% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 FENOFIBRATE Dopamine Transporter 69% 8.633uM 6.859uM View
A3 adenosine receptor FENOFIBRATE Adenosine A3 69% 5.701uM 3.222uM View
adrenergic receptor, beta 3 ERGOCORNINE Adrenergic beta3 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 SULCONAZOLE Calcium Channel Type L, Phenylalkylamine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 SULCONAZOLE Calcium Channel Type L, Phenylalkylamine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 SULCONAZOLE Calcium Channel Type L, Phenylalkylamine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 SULCONAZOLE Calcium Channel Type L, Phenylalkylamine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 SULCONAZOLE Calcium Channel Type L, Phenylalkylamine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 SULCONAZOLE Calcium Channel Type L, Phenylalkylamine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 SULCONAZOLE Calcium Channel Type L, Phenylalkylamine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit SULCONAZOLE Calcium Channel Type L, Phenylalkylamine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit SULCONAZOLE Calcium Channel Type L, Phenylalkylamine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit SULCONAZOLE Calcium Channel Type L, Phenylalkylamine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit SULCONAZOLE Calcium Channel Type L, Phenylalkylamine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit SULCONAZOLE Calcium Channel Type L, Phenylalkylamine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit SULCONAZOLE Calcium Channel Type L, Phenylalkylamine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit SULCONAZOLE Calcium Channel Type L, Phenylalkylamine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit SULCONAZOLE Calcium Channel Type L, Phenylalkylamine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit SULCONAZOLE Calcium Channel Type L, Phenylalkylamine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit SULCONAZOLE Calcium Channel Type L, Phenylalkylamine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit SULCONAZOLE Calcium Channel Type L, Phenylalkylamine 69% NoneNone NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) DACTINOMYCIN Protein Tyrosine Kinase, HER2 Receptor 66% NoneNone NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) DACTINOMYCIN Protein Tyrosine Kinase, HER2 Receptor 66% NoneNone NoneNone View
mitogen activated protein kinase 3 GRAMICIDIN Protein Serine/Threonine Kinase, ERK1 66% NoneNone NoneNone View
mitogen-activated protein kinase 3 GRAMICIDIN Protein Serine/Threonine Kinase, ERK1 66% NoneNone NoneNone View
dopamine receptor D4 PROMAZINE Dopamine D4.2 66% NoneNone NoneNone View
adrenergic receptor, alpha 1b TERCONAZOLE Adrenergic alpha1B 66% 14.299uM 7.915uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 TERCONAZOLE Serotonin Transporter 66% 11.456uM 6.086uM View
adrenergic receptor, alpha 1d (Non-specific probe) TERFENADINE Adrenergic alpha1D 66% NoneNone NoneNone View
mitogen activated protein kinase 3 NELFINAVIR Protein Serine/Threonine Kinase, ERK1 66% 22.503uM NoneNone View
mitogen-activated protein kinase 3 NELFINAVIR Protein Serine/Threonine Kinase, ERK1 66% 22.503uM NoneNone View
acetylcholinesterase (YT blood group) TERCONAZOLE Acetylcholinesterase 66% 21.573uM NoneNone View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase TERCONAZOLE Acetylcholinesterase 66% 21.573uM NoneNone View
acetylcholinesterase TERCONAZOLE Acetylcholinesterase 66% 21.573uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 1B PENTAMIDINE Serotonin 5-HT1B 66% NoneNone NoneNone View
epidermal growth factor receptor PROCHLORPERAZINE Protein Tyrosine Kinase, EGF Receptor 66% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 S-(-)-PROPRANOLOL Adrenergic, Norepinephrine Transporter 66% NoneNone NoneNone View
melanocortin 4 receptor GUANABENZ Melanocortin MC4 66% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 4 polypeptide MICONAZOLE ATPase, Na+/K+ 66% 19.279uM NoneNone View
ATPase, Na+/K+ transporting, alpha 3 polypeptide MICONAZOLE ATPase, Na+/K+ 66% 19.279uM NoneNone View
ATPase, Na+/K+ transporting, alpha 2 polypeptide MICONAZOLE ATPase, Na+/K+ 66% 19.279uM NoneNone View
ATPase, Na+/K+ transporting, alpha 1 polypeptide MICONAZOLE ATPase, Na+/K+ 66% 19.279uM NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit EMETINE Calcium Channel Type L, Phenylalkylamine 65% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit EMETINE Calcium Channel Type L, Phenylalkylamine 65% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit EMETINE Calcium Channel Type L, Phenylalkylamine 65% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit EMETINE Calcium Channel Type L, Phenylalkylamine 65% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit EMETINE Calcium Channel Type L, Phenylalkylamine 65% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit EMETINE Calcium Channel Type L, Phenylalkylamine 65% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 EMETINE Calcium Channel Type L, Phenylalkylamine 65% NoneNone NoneNone View
opioid receptor, sigma 1 DIPHENHYDRAMINE Sigma1 65% NoneNone NoneNone View
histamine receptor H 2 DIPHENHYDRAMINE Histamine H2 65% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 TROGLITAZONE Adrenergic, Norepinephrine Transporter 65% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 RESERPINE Adrenergic, Norepinephrine Transporter 65% NoneNone NoneNone View
mu-opioid receptor MOR CADMIUM CHLORIDE Opiate mu 65% NoneNone NoneNone View
lymphocyte protein tyrosine kinase (mapped) CADMIUM CHLORIDE Protein Tyrosine Kinase, Lck 65% NoneNone NoneNone View
cholinergic receptor, muscarinic 2 PRIMAQUINE Muscarinic M2 65% NoneNone NoneNone View
interleukin 8 receptor, beta CETYLPYRIDINIUM BROMIDE Chemokine CXCR2 (IL-8B) 65% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta SIBUTRAMINE Sodium Channel, Site 2 65% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha SIBUTRAMINE Sodium Channel, Site 2 65% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma SIBUTRAMINE Sodium Channel, Site 2 65% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta SIBUTRAMINE Sodium Channel, Site 2 65% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide SIBUTRAMINE Sodium Channel, Site 2 65% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha SIBUTRAMINE Sodium Channel, Site 2 65% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma SIBUTRAMINE Sodium Channel, Site 2 65% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta SIBUTRAMINE Sodium Channel, Site 2 65% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) SIBUTRAMINE Sodium Channel, Site 2 65% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha SIBUTRAMINE Sodium Channel, Site 2 65% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha SIBUTRAMINE Sodium Channel, Site 2 65% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha SIBUTRAMINE Sodium Channel, Site 2 65% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha SIBUTRAMINE Sodium Channel, Site 2 65% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha SIBUTRAMINE Sodium Channel, Site 2 65% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) SIBUTRAMINE Sodium Channel, Site 2 65% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta SIBUTRAMINE Sodium Channel, Site 2 65% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha SIBUTRAMINE Sodium Channel, Site 2 65% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha SIBUTRAMINE Sodium Channel, Site 2 65% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, beta 1 subunit MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 MAPROTILINE Calcium Channel Type L, Phenylalkylamine 71% .446uM .434uM View
lymphocyte protein tyrosine kinase (mapped) ERGOTAMINE Protein Tyrosine Kinase, Lck 71% 6.499uM NoneNone View
adrenergic receptor, beta 2 ERGOTAMINE Adrenergic beta2 71% 2.761uM 1.898uM View
sodium channel, voltage-gated, type IV, beta PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel associated protein 1 PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel associated protein 2 PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type III, beta PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type I, alpha PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type IX, alpha PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type VII, alpha PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
amiloride-sensitive cation channel 5, intestinal PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type III, beta PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type XI, alpha PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type I, beta PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type 10, alpha polypeptide PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type IV, alpha polypeptide PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type V, alpha polypeptide PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type II, beta PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, nonvoltage-gated 1 alpha PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, nonvoltage-gated 1 gamma PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, nonvoltage-gated 1 beta PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type XI, alpha PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, nonvoltage-gated 1, gamma PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 TRIHEXYPHENIDYL Calcium Channel Type L, Benzothiazepine 70% 4.81uM 4.275uM View
calcium channel, voltage-dependent, beta 3 subunit QUINACRINE Calcium Channel Type L, Benzothiazepine 70% 1.076uM .956uM View
calcium channel, voltage-dependent, beta 2 subunit QUINACRINE Calcium Channel Type L, Benzothiazepine 70% 1.076uM .956uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit QUINACRINE Calcium Channel Type L, Benzothiazepine 70% 1.076uM .956uM View
calcium channel, voltage-dependent, alpha 1F subunit QUINACRINE Calcium Channel Type L, Benzothiazepine 70% 1.076uM .956uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit QUINACRINE Calcium Channel Type L, Benzothiazepine 70% 1.076uM .956uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit QUINACRINE Calcium Channel Type L, Benzothiazepine 70% 1.076uM .956uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit QUINACRINE Calcium Channel Type L, Benzothiazepine 70% 1.076uM .956uM View
calcium channel, voltage-dependent, beta 1 subunit QUINACRINE Calcium Channel Type L, Benzothiazepine 70% 1.076uM .956uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit QUINACRINE Calcium Channel Type L, Benzothiazepine 70% 1.076uM .956uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit QUINACRINE Calcium Channel Type L, Benzothiazepine 70% 1.076uM .956uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 QUINACRINE Calcium Channel Type L, Benzothiazepine 70% 1.076uM .956uM View
histamine receptor H 2 NORTRIPTYLINE Histamine H2 70% 2.334uM 2.295uM View
5-hydroxytryptamine (serotonin) receptor 1B NORTRIPTYLINE Serotonin 5-HT1B 70% 3.199uM 1.454uM View
adrenergic receptor, alpha 2a NORTRIPTYLINE Imidazoline I2, Central 70% 3.858uM 2.572uM View
adrenergic receptor, alpha 2c (Non-specific probe) NORTRIPTYLINE Imidazoline I2, Central 70% 3.858uM 2.572uM View
A3 adenosine receptor STANOZOLOL Adenosine A3 70% 8.325uM 4.705uM View
adrenergic receptor, alpha 2b RALOXIFENE Adrenergic alpha2B 70% 3.698uM 1.688uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 SIBUTRAMINE Adrenergic, Norepinephrine Transporter 70% 5.665uM 5.619uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 SULCONAZOLE Calcium Channel Type L, Phenylalkylamine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 SULCONAZOLE Calcium Channel Type L, Phenylalkylamine 69% NoneNone NoneNone View
adrenergic receptor, beta 3 SULCONAZOLE Adrenergic beta3 69% NoneNone NoneNone View